These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27648019)

  • 1. Clinical efficacy and safety of hypernormal shortened door to needle time (DNT) plus individualized low-dose alteplase therapy in treating acute ischemic stroke.
    Zheng M; Lei H; Cui Y; Yang D; Wang L; Wang Z
    Pak J Med Sci; 2016; 32(4):811-6. PubMed ID: 27648019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke.
    Li H; Xu D; Xu Y; Wei L
    Front Surg; 2022; 9():888015. PubMed ID: 35574548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
    Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study.
    Dhar N; Kumar M; Tiwari A; Desai I; Madhaw G; Kumar N
    Ann Indian Acad Neurol; 2022; 25(5):897-901. PubMed ID: 36561006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world data of tenecteplase vs. alteplase in the treatment of acute ischemic stroke: a single-center analysis.
    Yao Y; Wu Y; Zhang X; Liu C; Cai L; Ying Y; Yang J
    Front Neurol; 2024; 15():1386386. PubMed ID: 38708004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
    Huang P; Yi XY
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9710-9720. PubMed ID: 37916334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world comparative safety and efficacy of tenecteplase
    Psychogios K; Palaiodimou L; Katsanos AH; Magoufis G; Safouris A; Kargiotis O; Spiliopoulos S; Papageorgiou E; Theodorou A; Voumvourakis K; Broutzos E; Stamboulis E; Tsivgoulis G
    Ther Adv Neurol Disord; 2021; 14():1756286420986727. PubMed ID: 33488774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
    Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
    Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical thrombectomy using a Solitaire stent retriever in the treatment of pediatric acute ischemic stroke.
    Zhou B; Wang XC; Xiang JY; Zhang MZ; Li B; Jiang HB; Lu XD
    J Neurosurg Pediatr; 2019 Jan; 23(3):363-368. PubMed ID: 30611154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rt-PA thrombolytic therapy in patients with acute posterior circulation stroke: A retrospective study.
    Hu Y; Zheng H; Chen X; Gao Z
    Med Int (Lond); 2022; 2(2):8. PubMed ID: 36699100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Analysis on Low- and Standard-Dose Regimes of Alteplase Thrombolytic Therapy for Acute Ischemic Stroke: Efficacy and Safety.
    Zhao G; Huang T; Zheng M; Cui Y; Liu Y; Cheng Z; Wang Z
    Eur Neurol; 2018; 79(1-2):68-73. PubMed ID: 29241193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis.
    Huang P; Yi X
    Int J Immunopathol Pharmacol; 2023; 37():3946320231204597. PubMed ID: 37771034
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose vs. standard-dose alteplase for Chinese patients with acute ischemic stroke: A propensity score analysis.
    Xu J; Chen X; Xie Y; Wang Y; Chen S; Dong Q; Dong Y; Fang K
    Front Neurol; 2023; 14():1120547. PubMed ID: 36895900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
    JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke.
    Zhai M; Cao S; Yang J; Cao X; Dong Z; Liu W; Fu Y; Guan Q; Wang Y; Liu H
    Neurol Ther; 2023 Aug; 12(4):1105-1118. PubMed ID: 37166676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of homocysteine levels on clinical outcome in patients with acute ischemic stroke receiving intravenous thrombolysis therapy.
    Li L; Ma X; Zeng L; Pandey S; Wan R; Shen R; Zhang Q
    PeerJ; 2020; 8():e9474. PubMed ID: 32728492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
    Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.